Gilles Guillemin
TitleCited byYear
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ...
Nature 478 (7368), 197, 2011
9452011
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification
GJ Guillemin, BJ Brew
Journal of leukocyte biology 75 (3), 388-397, 2004
5502004
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin, SJ Kerr, GA Smythe, DG Smith, V Kapoor, PJ Armati, ...
Journal of neurochemistry 78 (4), 842-853, 2001
3972001
Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats
N Braidy, GJ Guillemin, H Mansour, T Chan-Ling, A Poljak, R Grant
PloS one 6 (4), e19194, 2011
3862011
Innovation and SMEs: Misaligned perspectives and goals among entrepreneurs, academics, and policy makers
S Massa, S Testa
Technovation 28 (7), 393-407, 2008
3742008
Expression of indoleamine 2, 3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons
GJ Guillemin, G Smythe, O Takikawa, BJ Brew
Glia 49 (1), 15-23, 2005
3622005
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic†…
J Steiner, M Walter, T Gos, GJ Guillemin, HG Bernstein, Z Sarnyai, ...
Journal of neuroinflammation 8 (1), 94, 2011
3552011
Kynurenine pathway metabolites in humans: disease and healthy states
Y Chen, GJ Guillemin
International Journal of Tryptophan Research 2, IJTR. S2097, 2009
3512009
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
A Bessede, M Gargaro, MT Pallotta, D Matino, G Servillo, C Brunacci, ...
Nature 511 (7508), 184, 2014
3222014
Age-associated changes in oxidative stress and NAD+ metabolism in human tissue
H Massudi, R Grant, N Braidy, J Guest, B Farnsworth, GJ Guillemin
PloS one 7 (7), e42357, 2012
2582012
Indoleamine 2, 3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus
GJ Guillemin, BJ Brew, CE Noonan, O Takikawa, KM Cullen
Neuropathology and applied neurobiology 31 (4), 395-404, 2005
2432005
Characterization of the kynurenine pathway in human neurons
GJ Guillemin, KM Cullen, CK Lim, GA Smythe, B Garner, V Kapoor, ...
Journal of Neuroscience 27 (47), 12884-12892, 2007
2372007
Quinolinic acid, the inescapable neurotoxin
GJ Guillemin
The FEBS journal 279 (8), 1356-1365, 2012
2242012
Connecting inflammation with glutamate agonism in suicidality
S Erhardt, CK Lim, KR Linderholm, S Janelidze, D Lindqvist, ...
Neuropsychopharmacology 38 (5), 743, 2013
1922013
Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNFα and IFNγ in CXCR4 and CCR5 modulation
J Croitoru‐Lamoury, GJ Guillemin, FD Boussin, B Mognetti, LI Gigout, ...
Glia 41 (4), 354-370, 2003
1862003
Neuroprotective effect of natural products against Alzheimer’s disease
MM Essa, RK Vijayan, G Castellano-Gonzalez, MA Memon, N Braidy, ...
Neurochemical research 37 (9), 1829-1842, 2012
1822012
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-β peptide generation
WS Kim, AS Rahmanto, A Kamili, KA Rye, GJ Guillemin, IC Gelissen, ...
Journal of Biological Chemistry 282 (5), 2851-2861, 2007
1672007
Expression of the kynurenine pathway enzymes in human microglia and macrophages
GJ Guillemin, DG Smith, GA Smythe, PJ Armati, GJ Brew
Developments in Tryptophan and Serotonin Metabolism, 105-112, 2003
1672003
Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons
N Braidy, R Grant, S Adams, BJ Brew, GJ Guillemin
Neurotoxicity research 16 (1), 77-86, 2009
1632009
Neurodegeneration and ageing in the HAART era
BJ Brew, SM Crowe, A Landay, LA Cysique, G Guillemin
Journal of Neuroimmune Pharmacology 4 (2), 163, 2009
1622009
The system can't perform the operation now. Try again later.
Articles 1–20